GLP-1 drugs can lead to an increased risk of permanent vision loss
Conversely, ferroptosis inhibitors significantly attenuate 6-OHDA-induced neuronal damage ( /GPX4 signaling axis in the prefrontal cortex of AD mice, upregulates ferritin light chain (FTL) and -site amyloid precursor protein cleaving enzyme 1 (BACE1), downregulates 4-hydroxynonenal (4-HNE), inhibits ferroptosis and lipid peroxidation, and ameliorates cognitive deficits (Li et al., 2024a)
Radiolabeled trials indicate targeted peptide accumulation in the pancreas, liver, and adipose tissue, suggesting precise metabolic activity without systemic toxicity
Furthermore, this medicine has been shown to have positive effects on cardiovascular health
GLP-1 receptor agonists improve endothelial function Phase 3 status / Phase 3 trials ongoing as of mid-2025